BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33705624)

  • 1. Conditional Survival of Surgically Treated Patients with Lung Cancer: A Comprehensive Analyses of Overall, Recurrence-free, and Relative Survival.
    Shin DW; Cho JH; Yoo JE; Cho J; Yoon DW; Lee G; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
    Cancer Res Treat; 2021 Oct; 53(4):1057-1071. PubMed ID: 33705624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
    Rajaram R; Correa AM; Xu T; Nguyen QN; Antonoff MB; Rice D; Mehran R; Roth J; Walsh G; Swisher S; Hofstetter WL; Vaporciyan A; Cascone T; Tsao AS; Papadimitrakopoulou VA; Gandhi S; Liao Z; Sepesi B
    Clin Lung Cancer; 2020 Jul; 21(4):e294-e301. PubMed ID: 32089476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival.
    Mayne NR; Mallipeddi MK; Darling AJ; Jeffrey Yang CF; Eltaraboulsi WR; Shoffner AR; Naqvi IA; D'Amico TA; Berry MF
    Clin Lung Cancer; 2020 Sep; 21(5):407-414. PubMed ID: 32376115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival disparities following surgery among patients with different histological types of non-small cell lung cancer.
    Grosu HB; Manzanera A; Shivakumar S; Sun S; Noguras Gonzalez G; Ost DE
    Lung Cancer; 2020 Feb; 140():55-58. PubMed ID: 31865279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
    She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
    Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm.
    Blaauwgeers H; Damhuis R; Lissenberg-Witte BI; de Langen AJ; Senan S; Thunnissen E
    J Thorac Oncol; 2019 Mar; 14(3):459-467. PubMed ID: 30408568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".
    Ekeke CN; Mitchell C; Schuchert M; Dhupar R; Luketich JD; Okusanya OT
    Clin Lung Cancer; 2021 Jan; 22(1):e132-e135. PubMed ID: 33144072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
    Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
    Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer.
    Higashiyama M; Miyazaki R; Yamamoto H; Anayama T; Kikuchi S; Hirohashi K; Okami J; Maniwa T; Kimura T; Orihashi K; Imamura F
    BMC Cancer; 2020 Nov; 20(1):1100. PubMed ID: 33183251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
    J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
    Khorrami M; Bera K; Leo P; Vaidya P; Patil P; Thawani R; Velu P; Rajiah P; Alilou M; Choi H; Feldman MD; Gilkeson RC; Linden P; Fu P; Pass H; Velcheti V; Madabhushi A
    Lung Cancer; 2020 Apr; 142():90-97. PubMed ID: 32120229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.
    Fink-Neuboeck N; Lindenmann J; Porubsky C; Fediuk M; Anegg U; Maier A; Smolle J; Lamont E; Smolle-Juettner FM
    Clin Lung Cancer; 2020 Jul; 21(4):333-340. PubMed ID: 32273257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.
    Kastelijn EA; El Sharouni SY; Hofman FN; Van Putte BP; Monninkhof EM; Van Vulpen M; Schramel FM
    Anticancer Res; 2015 Oct; 35(10):5607-14. PubMed ID: 26408733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.
    Martini N; Rusch VW; Bains MS; Kris MG; Downey RJ; Flehinger BJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1999 Jan; 117(1):32-6; discussion 37-8. PubMed ID: 9869756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Survival in Complete Pathologic Response Non-Small Cell Lung Cancer.
    Martinez-Meehan D; Lutfi W; Dhupar R; Christie N; Baker N; Schuchert M; Luketich JD; Okusanya OT
    Clin Lung Cancer; 2020 Jul; 21(4):349-356. PubMed ID: 32299769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study.
    Wei W; Zhou J; Zhang Q; Liao DH; Liu QD; Zhong BL; Liang ZB; Zhang YC; Jiang R; Liu GY; Xu CY; Li Zhou H; Zhu SY; Yang N; Jiang W; Liu ZG
    Cancer Med; 2020 Apr; 9(8):2820-2832. PubMed ID: 32100444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Huang BS; Wu YC
    J Thorac Oncol; 2012 Feb; 7(2):397-405. PubMed ID: 22173701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer.
    Wang C; Wu Y; Shao J; Liu D; Li W
    BMC Cancer; 2020 Feb; 20(1):150. PubMed ID: 32093621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.